Subsequent Events (Details) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 05, 2022 |
Mar. 07, 2022
USD ($)
|
Mar. 03, 2022
USD ($)
|
Mar. 01, 2022 |
Oct. 25, 2021
USD ($)
|
Oct. 24, 2022
USD ($)
|
Oct. 20, 2022
USD ($)
$ / shares
|
Sep. 15, 2022
USD ($)
|
Jun. 17, 2021
USD ($)
|
Sep. 30, 2022
USD ($)
$ / shares
shares
|
Sep. 30, 2022
USD ($)
$ / shares
shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2021
AUD ($)
shares
|
Dec. 31, 2020
$ / shares
shares
|
|
| Subsequent Events (Details) [Line Items] | ||||||||||||||
| Warrants exercised (in Shares) | shares | 4,227,114 | 4,227,114 | ||||||||||||
| Cancellation of warrants (in Shares) | shares | 4,227,114 | |||||||||||||
| Common stock, share issued (in Shares) | shares | 24,469,675 | 24,469,675 | 16,691,170 | 8,736,378 | ||||||||||
| Gross proceeds | $ 2,659,750 | $ 3,407,250 | $ 796,000 | $ 354,994 | ||||||||||
| Net proceeds | $ 75,000 | $ 190,000 | ||||||||||||
| Common stock, per share (in Dollars per share) | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||
| Proceeds from sale | $ 750,000 | |||||||||||||
| Agreement to pay | $ 750,000 | |||||||||||||
| Gross proceeds percentage | 50.00% | |||||||||||||
| Description of warrants | The Replacement Warrants reflect a reduction in the number of Series C and Series D Warrants from 1,550,000 in each class to 1,536,607 in each class and a reduction in the number of Series E and Series F Warrants from 1,075,000 in each class to 807,143 in each class, and the initial exercise date for the Replacement Warrants are unchanged from the date as set forth in the respective exchanged Series C, Series D, Series E or Series F Warrant. | |||||||||||||
| Note conversion, description | Subsequent to December 31, 2021, a total of $168,850 in principal of convertible notes converted into 109,435 shares of common stock. | Subsequent to December 31, 2021, a total of $168,850 in principal of convertible notes converted into 109,435 shares of common stock. | ||||||||||||
| Net proceeds | $ 2,213,500 | $ 224,540 | ||||||||||||
| Common stock shares to consultants (in Shares) | shares | 183,590 | 183,590 | ||||||||||||
| Common Stock [Member] | ||||||||||||||
| Subsequent Events (Details) [Line Items] | ||||||||||||||
| Common stock, share issued (in Shares) | shares | 3,802,626 | 3,802,626 | ||||||||||||
| One Promissory Note [Member] | ||||||||||||||
| Subsequent Events (Details) [Line Items] | ||||||||||||||
| Net proceeds | $ 300,000 | |||||||||||||
| Subsequent Event [Member] | ||||||||||||||
| Subsequent Events (Details) [Line Items] | ||||||||||||||
| Investor purchase | $ 1,500,000 | $ 15,000,000 | ||||||||||||
| Common stock, per share (in Dollars per share) | $ / shares | $ 0.001 | |||||||||||||
| Weighted average | 82.00% | |||||||||||||
| Principal amount | $ 300,000 | |||||||||||||
| Purchase price | $ 255,000 | |||||||||||||
| Debt Instrument, Interest Rate, Effective Percentage | 10.00% | |||||||||||||
| Payments to investor | $ 47,142.85 | |||||||||||||
| Unsecured debenture | $ 1,666,650 | |||||||||||||
| Securities purchase agreement , description | The Debenture has an original issue discount of 10%, has a term of six months with a maturity date of April 24, 2023, may be extended by six months at the Company’s option subject to certain conditions, and are convertible into shares of Common Stock at a conversion price of $0.20 per share, subject to adjustment upon certain events. | |||||||||||||
| Forecast [Member] | ||||||||||||||
| Subsequent Events (Details) [Line Items] | ||||||||||||||
| Securities purchase agreement , description | the Company entered into securities purchase agreements with twenty-eight accredited investors whereby, at the closing, such investors purchased from the Company an aggregate of 1,401,457 shares of the Company’s common stock and (ii) 1,401,457 warrants to purchase shares of common stock, for an aggregate purchase price of $2,452,550. Such warrants are exercisable for a term of five-years from the date of issuance, at an exercise price of $1.75 per share. | |||||||||||||
| Registered direct offering, description | the Company entered into a securities purchase agreement (the “Purchase Agreement”) with thirteen accredited investors resulting in the raise of $2,659,750 in gross proceeds to the Company. Pursuant to the terms of the Purchase Agreement, the Company agreed to sell in a registered direct offering an aggregate of 1,519,857 shares of the Company’s common stock together with warrants to purchase an aggregate of 1,519,857 shares of Common Stock at an exercise price of $1.75 per share. The warrants are immediately exercisable and will expire on March 9, 2027. | |||||||||||||
| Certain debts and liabilities | $ 278,163 | |||||||||||||
| Settlement total | $ 799,000 | |||||||||||||
| Note principal | 660,000 | |||||||||||||
| Accrued interest | $ 139,000 | |||||||||||||
| Employment agreements, description | On April 5, 2022, upon the recommendation of the Compensation Committee of the Board, the Board approved employment agreements with, and equity issuances for, (i) Jeremy Frommer, Executive Chairman, who will receive (a) an signing award of $80,000, (b) an annual salary of $420,000; (c) 121,000 options, to vest immediately with a strike price of $1.75, and (d) 50,000 shares of the Company’s restricted common stock; (ii) Laurie Weisberg, Chief Executive Officer, who will receive (a) an annual salary of $475,000; (b) 121,000 options, to vest immediately with a strike price of $1.75, and (c) 50,000 shares of the Company’s restricted common stock; (iii) Justin Maury, Chief Operating Officer & President, who will receive (a) an annual salary of $475,000 (b) 81,000 options, to vest immediately with a strike price of $1.75, and (c) 50,000 shares of the Company’s restricted common stock; and (iv) Chelsea Pullano, Chief Financial Officer, who will receive (a) an annual salary of $250,000; (b) 37,000 options, to vest immediately with a strike price of $1.75, and (c) 35,000 shares of the Company’s restricted common stock (collectively, the “Executive Employment Arrangements”). | |||||||||||||
| Promissory Notes [Member] | ||||||||||||||
| Subsequent Events (Details) [Line Items] | ||||||||||||||
| Net proceeds | $ 100,000 | |||||||||||||